OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Riboswitches as Drug Targets for Antibiotics
Vipul Panchal, Ruth Brenk
Antibiotics (2021) Vol. 10, Iss. 1, pp. 45-45
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Discovering riboswitches: the past and the future
Kumari Kavita, Ronald R. Breaker
Trends in Biochemical Sciences (2022) Vol. 48, Iss. 2, pp. 119-141
Open Access | Times Cited: 165

Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections
Ursula Theuretzbacher, Benjamin Blasco, Maëlle Duffey, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 957-975
Closed Access | Times Cited: 43

Riboswitches as therapeutic targets: promise of a new era of antibiotics
Emily Ellinger, Adrien Chauvier, Rosa A. Romero, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 433-445
Closed Access | Times Cited: 24

Flipping the script: Understanding riboswitches from an alternative perspective
Lukasz T. Olenginski, Savannah Spradlin, Robert Batey
Journal of Biological Chemistry (2024) Vol. 300, Iss. 3, pp. 105730-105730
Open Access | Times Cited: 13

Small molecule targeting of biologically relevant RNA tertiary and quaternary structures
Martina Zafferani, Amanda E. Hargrove
Cell chemical biology (2021) Vol. 28, Iss. 5, pp. 594-609
Open Access | Times Cited: 43

Penicillin-binding proteins: the master builders and breakers of bacterial cell walls and its interaction with β-lactam antibiotics
Milan Dabhi, R. B. Patel, Vidhi Shah, et al.
Journal of Proteins and Proteomics (2024) Vol. 15, Iss. 2, pp. 215-232
Closed Access | Times Cited: 9

The emerging role of bacterial regulatory RNAs in disease
Hannes Eichner, Jens Karlsson, Edmund Loh
Trends in Microbiology (2022) Vol. 30, Iss. 10, pp. 959-972
Open Access | Times Cited: 27

Microbial Genomics: Innovative Targets and Mechanisms
Asma Hussain Alkatheri, Polly Soo Xi Yap, Aisha Abushelaibi, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 190-190
Open Access | Times Cited: 17

Affinity selection mass spectrometry speeding drug discovery
Renaud Prudent, Hugues Lemoine, Jarrod Walsh, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103760-103760
Closed Access | Times Cited: 16

Current Strategies for Combating Biofilm-Forming Pathogens in Clinical Healthcare-Associated Infections
Rashmita Biswas, Bhawana Jangra, Ganapathy Ashok, et al.
Indian Journal of Microbiology (2024) Vol. 64, Iss. 3, pp. 781-796
Closed Access | Times Cited: 5

Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises
Natesh Singh, Bruno O. Villoutreix
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2537-2548
Open Access | Times Cited: 28

Fragment‐Based Drug Discovery for RNA Targets
Kasper P. Lundquist, Vipul Panchal, Charlotte H. Gotfredsen, et al.
ChemMedChem (2021) Vol. 16, Iss. 17, pp. 2588-2603
Open Access | Times Cited: 28

A Riboswitch-Driven Era of New Antibacterials
Νικολέτα Γιαρίμογλου, Adamantia Kouvela, Alexandros Maniatis, et al.
Antibiotics (2022) Vol. 11, Iss. 9, pp. 1243-1243
Open Access | Times Cited: 23

Riboswitch Mechanisms for Regulation of P1 Helix Stability
Jason R. Stagno, Yun‐Xing Wang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10682-10682
Open Access | Times Cited: 4

Affinity-Based Profiling of the Flavin Mononucleotide Riboswitch
Stefan Crielaard, R. Maassen, Tess Vosman, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 23, pp. 10462-10470
Open Access | Times Cited: 19

Transcriptional regulation and drug resistance in Mycobacterium tuberculosis
Paolo Miotto, Rita Sorrentino, Stefano De Giorgi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 19

Protein-Based Virtual Screening Tools Applied for RNA–Ligand Docking Identify New Binders of the preQ1-Riboswitch
Elisabeth Kallert, Tim R. Fischer, Simon Schneider, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 17, pp. 4134-4148
Open Access | Times Cited: 17

Exploring antibiotic resistance with chemical tools
Willem A. Velema
Chemical Communications (2023) Vol. 59, Iss. 41, pp. 6148-6158
Open Access | Times Cited: 10

Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch
Vera Hedwig, Maike Spöring, Gary E. Aspnes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Secondary-Structure-Informed RNA Inverse Design via Relational Graph Neural Networks
Amirhossein Manzourolajdad, Mohammad Mohebbi
Non-Coding RNA (2025) Vol. 11, Iss. 2, pp. 18-18
Open Access

Targeting Gene Transcription Prevents Antibiotic Resistance
Paul F. Agris
Antibiotics (2025) Vol. 14, Iss. 4, pp. 345-345
Open Access

The thiamin pyrophosphate riboswitch is affected by lysine-derived metabolic conversion products in Escherichia coli
Shirin Jahangirnejad, Jean‐Philippe Côté, Daniel A. Lafontaine
Journal of Molecular Biology (2025), pp. 169207-169207
Open Access

Novel Alkaloids from Marine Actinobacteria: Discovery and Characterization
Anne-Sofie De Rop, Jeltien Rombaut, Thomas Willems, et al.
Marine Drugs (2021) Vol. 20, Iss. 1, pp. 6-6
Open Access | Times Cited: 22

Page 1 - Next Page

Scroll to top